Uric acid plasma level and urine pH in rats treated with ambroxol.
It was a chance discovery that ambroxol parenteral administration led to urinary bladder stone formation in rats. This study was undertaken to examine the serum uric acid levels and urine pH in rats after ambroxol parenteral treatment. Ambroxol influence on the uric acid level was measured in 5 rats (Rattus sp.) treated with 60 mg/kg (dissolved in injection water, sc, daily) during 2 weeks. Ambroxol influence on urine pH was examined on 45 rats divided into 3 groups. Rats from the 1st and 2nd group received 30 and 60 mg/kg/24h ambroxol, respectively. Urine was collected once daily and measured with strip kit. All values were presented as the means with standard deviations. The Student t test was used to compare the means, p < 0.05 was considered as significant. Dynamics of pH changes was measured in 4 rats treated with 60 mg/kg/24h of ambroxol. Controls received 1 mL of injection water sc. Serum uric acid level increased up to 8.7 +/- 1.0 mg/dL vs. 5.7 +/- 1.0 mg/dL in control (p < 0.002). In the 1st and 2nd group urine pH increased up to 7.5 +/- 0.5 and 7.6 +/- 0.5 vs. 6.7 +/- 0.4 (p < 0.05). Ambroxol withdrawal resulted in sequential urine pH decrease. 11 days after interruption of ambroxol therapy pH reached the starting value. Urine pH changes and possible disturbances in uric acid metabolic pathway may influence on the stone formation in rats after ambroxol parenteral treatment. The influence of ambroxol on urinary tract GAG layer and the balance between xanthine and CaOx in the urine should be checked.
Drewa
Tomasz
T
Department of Tissue Engineering, Chair of Medical Biology, N. Copernicus University, Bydgoszcz, Poland. tomaszdrewa@wp.pl
Wolski
Zbigniew
Z
Gruszka
Marzena
M
Misterek
Bartosz
B
Lysik
Joanna
J
D000551:Ambroxol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005100:Expectorants / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration / Q000187:drug effects*; D007279:Injections, Subcutaneous; D051381:Rats; D013997:Time Factors; D014527:Uric Acid / Q000097:blood* / Q000378:metabolism; D016482:Urinalysis; D014556:Urine / Q000737:chemistry
D005100:Expectorants; D000551:Ambroxol; D014527:Uric Acid